David M. Knott’s Kyntra Bio KYNB Stock Holding History

David M. Knott’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-400	Closed	-$371K	–	135
2020 Q4	$371K	Sell	400 -389	-49%	-$409K	0.17%	63
2020 Q3	$811K	Buy	+789	New	+$849K	0.48%	40

Other funds holding KYNB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

David M. Knott's KYNB Position: Q1 2021 in Review

David M. Knott sold out of Kyntra Bio (KYNB) in Q1 2021, closing a stake of 400 shares — an estimated $371K sold.

David M. Knott first reported a position in KYNB in Q3 2020 and held it in 2 quarters. The position peaked at $811K in Q3 2020. 198 funds tracked by Wall St. Rank hold KYNB as of Q1 2021.

David M. Knott reported no remaining Kyntra Bio position as of Q1 2021 after selling out during the quarter.
David M. Knott sold 400 Kyntra Bio shares in Q1 2021, an estimated $371K.
David M. Knott first reported a position in Kyntra Bio in Q3 2020 and held it in 2 quarters.
David M. Knott's Kyntra Bio position peaked at $811K in Q3 2020.
198 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2021.

Based on David M. Knott's 13F filing for Q1 2021, filed 13 May 2021.